🇺🇸 FDA
Patent

US 6476017

Compounds activating pharmacological effect of retinoids

expired A61PA61P19/08A61P35/02

Quick answer

US patent 6476017 (Compounds activating pharmacological effect of retinoids) held by Institute of Medicinal Molecular Design, Inc. expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Institute of Medicinal Molecular Design, Inc.
Grant date
Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P19/08, A61P35/02, A61P37/00